Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1975 Apr;53(4):539-46.
doi: 10.1111/j.1476-5381.1975.tb07392.x.

A chemotactic role for prostaglandins released from polymorphonuclear leucocytes during phagocytosis

A chemotactic role for prostaglandins released from polymorphonuclear leucocytes during phagocytosis

G A Higgs et al. Br J Pharmacol. 1975 Apr.

Abstract

1. Prostaglandin E1 is chemotactic at concentrations down to 10 ng/ml for rabbit polymorphonuclear (PMN) leucocytes. Prostaglandins E2 and F2alpha have little or no chemotactic effect at concentrations up to 10 mug/ml. 2. Washed PMN leucocytes produced a chemotactic agent during phagocytosis, but not in the presence of indomethacin (28 muM). 3. Phagocytosing PMN leucocytes produce up to ten times as much prostaglandin as do resting cells. Some of this is prostaglandin E1 as judged by thin layer chromatography and differential bioassay. This prostaglandin production by PMN leucocytes is abolished by indomethacin (28 muM). 4. Ultrasonicated suspensions of PMN leucocytes produced prostaglandin from arachidonic aicd. This synthesis is inhibited by indomethacin. 5. Homogenates of PMN leucocytes which have been pre-incubated withe bacteria for 30 min show more prostaglandin synthetase activity than homogenates from PMN leucocytes which have not been exposed to bacteria. 6. It is concluded that in some forms of inflammation, prostaglandin E1 may play a controlling role in cellular migration. 7. PMN leucocytes may contribute to the generation of prostaglandins found in some inflammatory lesions.

PubMed Disclaimer

References

    1. J Lipid Res. 1964 Jan;5:117-20 - PubMed
    1. J Exp Med. 1962 Mar 1;115:453-66 - PubMed
    1. J Exp Med. 1960 Mar 1;111:309-22 - PubMed
    1. Br J Pharmacol Chemother. 1957 Sep;12(3):344-9 - PubMed
    1. Br J Pharmacol. 1971 Jan;41(1):49-56 - PubMed

LinkOut - more resources